Condition (MeSH)
Cholestasis, Extrahepatic
ClinicalTrials.gov lists 16 trials for Cholestasis, Extrahepatic or a narrower condition beneath it. Boston Scientific Corporation has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
16 of the 16 trials are tagged with Cholestasis, Extrahepatic itself; the rest are tagged with a narrower condition beneath it.
When did Cholestasis, Extrahepatic trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2021 | 1 |
| 2019 | 3 |
| 2018 | 2 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 1 |
| 2014 | 2 |
| 2011 | 1 |
| 2008 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cholestasis, Extrahepatic trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 2 |
| Not applicable | 10 |
| Observational | 4 |
How many Cholestasis, Extrahepatic trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 9 |
| Terminated | 1 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cholestasis, Extrahepatic trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Boston Scientific Corporation | 1 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| EC Aspirin | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Cholestasis, Extrahepatic trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pancreatic Carcinoma | 18 | 1 |
| Pancreatic Carcinoma Metastatic | 8 | 1 |
| Deep vein thrombosis | 4 | 1 |
| Abdominal pain upper | 3 | 1 |
| Dyspnoea | 3 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Cholestasis, Extrahepatic? (56)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial. | Gastrointestinal endoscopy | 2023 | Yes |
| Efficacy of EUS-guided and ERCP-guided biliary drainage for malignant biliary obstruction: prospective randomized controlled study. | Gastrointestinal endoscopy | 2018 | Yes |
| Covered versus uncovered self-expandable metal stent for palliation of primary malignant extrahepatic biliary strictures: a randomized multicenter study. | Gastrointestinal endoscopy | 2018 | Yes |
| Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. | Endoscopy | 2018 | Yes |
| Percutaneous transhepatic versus EUS-guided gallbladder drainage for malignant cystic duct obstruction. | Gastrointestinal endoscopy | 2017 | Yes |
Showing 5 of 56 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.